Objective To establish conditionally regulated transgenic mice expressing hepatitis C virus(HCV) NS3 4A serine protease.Methods A recombinant plasmid PBI-Ⅲ/LoxP-Luc-PolyA-LoxP-NS3/4A was constructed by molecular cloning and transgenic mice were generated by microinjection of fertilized ovum with the larger linearized fragment obained by enzyme digesting the recombinant vector.Founder mouse and positive offsprings detected by polymerase chain reaction(PCR) were interbred with C57BL/6 mouse to establish a defined genetic background.Part of the second generations were interbred with another transgenic mouse Lap which have been stable and systematically constructed.The interbred dual transgenic offsprings previously induced with doxycycline(Dox) were detected by in vivo bioluminescent imaging(BLI).The imaging positive dual transgenics were reserved and their NS3/4A transgenic parents were interbred with C57BL/6 instead.Results Restriction analysis and sequence analysis showed that the recombinant plasmid PBI-Ⅲ/LoxP-Luc-PolyA-LoxP-NS3/4A was successfully constructed.6 founder transgenic mouse were obtained and 3 of them have been spread to fourth generation.Transgenic mouse stably expressing the exogenous reporter gene luciferase(Luc) were selected by BLI.Conclusion Transgenic mouse conditionally expressing HCV NS3/4A serine protease were successfully generated.
[1]Thompson AJ,McHutchison JG.Investigational agentsfor chronic hepatitis C[J].Aliment Pharmacol Ther,2009,29(7):689-705.
|
[2]Lange CM,Sarrazin C,Zeuzem S.Specifically targetedanti-viral therapy for hepatitis C-a new era intherapy[J].Aliment Pharmacol Ther,2010,32(1):14-28.
|
[3]Foy E,Li K,Sumpter R,et al.Regulation of interferonregulatory factor-3 by the hepatitis C virus serine protease[J].Science,2003,300(5622):1145-1148.
|
[4]Seth RB,Sun L,Chen ZJ.Antiviral innate immunitypathways[J].Cell Res,2006,16(2):141-147.
|
[5]Hiscott J,Lacoste J,Lin R.Recruitment of an interferonmolecular signaling complex to the mitochondrialmembrane:disruption by hepatitis C virus NS3-4Aprotease[J].Biochem Pharmacol,2006,72(11):1477-1484.
|
[6]Dothager RS,Flentie K,Moss B,et al.Advances inbioluminescence imaging of live animal models[J].CurrOpin Biotechnol,2009,20(1):45-53.
|
[7]Prescher JA,Contag CH.Guided by the light:visualizing biomolecular processes in living animals withbioluminescence[J].Curr Opin Chem Biol,2010,14(1):80-89.
|
[8]Luker KE,Luker GD.Applications of bioluminescenceimaging to antiviral research and therapy:multipleluciferase enzymes and quantitation[J].Antiviral Res,2008,78(3):179-187.
|
[9]Katinka MD,Bourgain FM.Mechanism of chromosomalintegration of transgenes in microinjected mouseeggs:sequence analysis of genome-transgene andtransgene-transgene junctions at two loci[J].EMBO J,1992,11(2):725-732.
|
[10]McFarlane M,Wilson JB.A model for the mechanismof precise integration of a microinjected transgene[J].Transgenic Res,1996,5(3):171-177.
|
[11]Bishop JO,Smith P.Mechanism of chromosomalintegration of microinjected DNA[J].Mol Biol Med,1989,6(4):283-298.
|